The Supreme Court Sides with the FDA on the Abortion Pill – For Now
Document Type
Article
Publication Date
6-13-2024
Publisher
The Nation Company, L.P.
Language
en-US
Abstract
When the US Supreme Court held Thursday that the plaintiffs in Alliance for Hippocratic Medicine v. FDA do not have standing to bring a challenge to the FDA’s regulation of mifepristone, despite their “sincere, legal, moral, ideological, and policy objections to elective abortion,” the justices stopped short of asserting that it is the FDA that has the authority to regulate drugs in the United States. Instead, the court left open the possibility of future challenges to the FDA’s regulation of the abortion pill when Justice Brett Kavanaugh, who wrote the opinion in the unanimous decision, noted that, while these plaintiffs lacked standing, “it is not clear that no one else would have standing to challenge the FDA’s relaxed regulation of mifepristone.”
Recommended Citation
Aziza Ahmed,
The Supreme Court Sides with the FDA on the Abortion Pill – For Now
,
The Nation
(2024).
Available at:
https://scholarship.law.bu.edu/shorter_works/267
Publisher URL
https://www.thenation.com/article/society/supreme-court-fda-mifepristone-abortion/
